KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Cash & Current Investments (2016 - 2025)

Travere Therapeutics' Cash & Current Investments history spans 13 years, with the latest figure at $93.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 58.94% year-over-year to $93.0 million; the TTM value through Dec 2025 reached $93.0 million, up 58.94%, while the annual FY2025 figure was $93.0 million, 58.94% up from the prior year.
  • Cash & Current Investments reached $93.0 million in Q4 2025 per TVTX's latest filing, down from $110.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $256.6 million in Q1 2022 to a low of $32.3 million in Q2 2024.
  • Average Cash & Current Investments over 5 years is $107.2 million, with a median of $88.2 million recorded in 2021.
  • Peak YoY movement for Cash & Current Investments: crashed 74.76% in 2024, then surged 204.68% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $165.8 million in 2021, then crashed by 62.78% to $61.7 million in 2022, then decreased by 5.69% to $58.2 million in 2023, then rose by 0.62% to $58.5 million in 2024, then soared by 58.94% to $93.0 million in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Cash & Current Investments are $93.0 million (Q4 2025), $110.9 million (Q3 2025), and $75.2 million (Q2 2025).